Simulations Plus, Inc. · NASDAQ:SLP

Simulations Plus — 17th Annual Craig-Hallum Institutional Investor Conference (May 2020)

13 slides from Simulations Plus's conference presentation, May 27, 2020

  1. Slide 1: 17th Annual Craig-Hallum Institutional Investor Conference

    17th Annual Craig-Hallum Institutional Investor Conference Shawn O’Connor Chief Executive Officer Simulations Plus, Inc. [email protected] Nasdaq: SLP

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement With the exception of historical information, the matters discussed in this presentation are forward-looking statements that involve a number of risks and uncertainties. The actual results of the Company could differ significantly from those statements. Factors that could cause

  3. Slide 3: Simulations Plus

    Simulations Plus Our mission is to improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services Products & Services Customers and Market Consistent Financial Pharmaceutical and biotech compan

  4. Slide 4: Serving All Stages of the Development Process

    Serving All Stages of the Development Process Our products and services span the entire drug development process from discovery to approval Software Product Portfolio • Physiologically-based pharmacokinetic (PBPK) modeling platform simulates a number of responses in humans and animals • Predicts ove

  5. Slide 5: Steady and Consistent Revenue Growth

    Steady and Consistent Revenue Growth Organic Revenue Growth accelerating to new 15-20% range Second Quarter Revenue $ in millions $10.3 Key Highlights $8.5 $7.4 • Q2 FY2020 Financial Highlights $5.0 $5.7 $3.8 – Revenue up 22.2% for Q2FY20 vs Q2FY19 $5.2 $3.2 $1.9 – Gross profit 74.2% for Q2FY20 vs 7

  6. Slide 6: Lixoft

    Lixoft Acquired April 1st, 2020 • Founded in 2011 with headquarters in Paris, France • Monolix Suite: PKPD Modeling functionality • Datxplore: Exploration and visualization of data • PKanalix: Non-compartmental and compartmental analysis • Mlxplore: Exploration and visualization of complex models •

  7. Slide 7: COVID-19 Impact

    COVID-19 Impact • Financial Stability – Operational transition has been effected smoothly; workforce is engaged in support of our clients productively and efficiently. – Strong balance sheet with ample cash – High percentage of revenues based upon software renewals for which we have seen no impact t

  8. Slide 8: Consolidated Revenues: Fiscal Quarter

    Consolidated Revenues: Fiscal Quarter (in millions) 2016 2017 2018 2019 2020 $11 $10.3 $9.9 $10 $9.4 $9 $8.6 $8.5 $8.0 $8 $7.5 $7.4 $7.1 $7 $6.8 $6.7 $6.3 $6.0 $6 $5.7 $5.4 $5.2 $5 $4.8 $4.0 $4 $3 $2 $1 $0 Q1 Q2 Q3 Q4 8

  9. Slide 9: Consolidated Income from Operations: Fiscal Quarter

    Consolidated Income from Operations: Fiscal Quarter (in millions) $4.5 $4.0 $3.9 $3.5 $3.4 $3.1 $3.0 $2.8 $2.8 $2.7 $2.7 $2.6 $2.5 $2.4 $2.1 $2.0 $2.0 $1.9 $1.9 $1.8 $1.7 $1.7 $1.5 $1.4 $1.0 $1.0 $0.5 $0.0 Q1 Q2 Q3 Q4 2016 2017 2018 2019 2020 9

  10. Slide 10: Consolidated Diluted Earnings Per Share: Fiscal Quarter

    Consolidated Diluted Earnings Per Share: Fiscal Quarter $0.20 $0.19 $0.18 $0.16 $0.16 $0.14 $0.13 $0.12 $0.12 $0.12 $0.12 $0.11 $0.11 $0.11 $0.11 $0.10 $0.10 $0.09 $0.08 $0.08 $0.07 $0.07 $0.07 $0.06 $0.06 $0.06 $0.05 $0.04 $0.02 $0.00 Q1 Q2 Q3 Q4 FY16 FY17 FY18 FY19 FY20 10 Note: 2Q18 $0.08 tax ben

  11. Slide 11: Consolidated EBITDA: Fiscal Quarter

    Consolidated EBITDA: Fiscal Quarter (in millions) $5 $4.6 $4.1 $4 $3.6 $3.4 $3.4 $3.5 $3.3 $3.2 $3.1 $3 $2.8 $2.7 $2.6 $2.5 $2.3 $2.2 $2.2 $2.0 $2 $1.5 $1 $0 Q1 Q2 Q3 Q4 2016 2017 2018 2019 2020 11

  12. Slide 12: Cash Position Excellent

    Cash Position Excellent (in millions) Accumulating Cash while funding Acquisitions and Dividends Dividend Paid Acquisitions Cash on Hand Net Cash paid $12.6 for Lixoft Cash paid for $12.2 ($ 6.0M) DILIsym $11.4 $10.3 $9.9 $9.4 $9.4 $8.8 $8.2 $8.0 $7.4 $7.5 $7.2 $7.0 Cash paid for DILIsym Cash paid $

  13. Slide 13: Thank you!

    Thank you! https://www.linkedin.com/company/simulations-plus https://www.linkedin.com/company/cognigen https://www.linkedin.com/company/dilisym https://www.linkedin.com/company/lixoft/ 13

Simulations Plus — 17th Annual Craig-Hallum Institutional Investor Conference (May 2020) on 6ix